These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35646120)

  • 1. Long Noncoding RNA SNHG16 Regulates the Growth of Human Lung Cancer Cells by Modulating the Expression of Aldehyde Dehydrogenase 2 (ALDH2).
    Li Y; Jiang L; Zhu Z; Fu B; Sun X; Jiao Y
    J Oncol; 2022; 2022():2411642. PubMed ID: 35646120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.
    Yu L; Chen D; Song J
    Thorac Cancer; 2020 Mar; 11(3):603-611. PubMed ID: 31953899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA SNHG16 drives proliferation, migration, and invasion of lung cancer cell through modulation of miR-520/VEGF axis.
    Chen L; Qiu CH; Chen Y; Wang Y; Zhao JJ; Zhang M
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9522-9531. PubMed ID: 33015794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced expression of the long non-coding RNA SNHG16 contributes to gastric cancer progression and metastasis.
    Lian D; Amin B; Du D; Yan W
    Cancer Biomark; 2017 Dec; 21(1):151-160. PubMed ID: 29081409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA SNHG16 Facilitates Nasopharyngeal Carcinoma Progression by Acting as ceRNA to Sponge miR-520a-3p and Upregulate MAPK1 Expression.
    Wu Q; Zhao Y; Shi R; Wang T
    Cancer Manag Res; 2021; 13():4103-4114. PubMed ID: 34045897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA SNHG16 promotes the tumorigenicity of cervical cancer cells by recruiting transcriptional factor SPI1 to upregulate PARP9.
    Tao L; Wang X; Zhou Q
    Cell Biol Int; 2020 Mar; 44(3):773-784. PubMed ID: 31774223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 3-Tetrazolyl Methyl-3-Hydroxy-Oxindole Hybrid (THOH) on Cell Proliferation, Apoptosis, and G2/M Cell Cycle Arrest Occurs by Targeting Platelet-Derived Growth Factor D (PDGF-D) and the MEK/ERK Signaling Pathway in Human Lung Cell Lines SK-LU-1, A549, and A-427.
    Li P; Zhang Z; Zhang F; Zhou H; Sun B
    Med Sci Monit; 2018 Jul; 24():4547-4554. PubMed ID: 29961751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA SNHG16 promotes proliferation, migration and invasion of osteosarcoma cells by targeting miR-1301/BCL9 axis.
    Wang X; Hu K; Chao Y; Wang L
    Biomed Pharmacother; 2019 Jun; 114():108798. PubMed ID: 30909141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNHG16 Silencing Inhibits Neuroblastoma Progression by Downregulating HOXA7 via Sponging miR-128-3p.
    Bao J; Zhang S; Meng Q; Qin T
    Neurochem Res; 2020 Apr; 45(4):825-836. PubMed ID: 31919621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA SNHG16 contributes to the development of bladder cancer via regulating miR-98/STAT3/Wnt/β-catenin pathway axis.
    Feng F; Chen A; Huang J; Xia Q; Chen Y; Jin X
    J Cell Biochem; 2018 Nov; 119(11):9408-9418. PubMed ID: 30132983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Myc induced upregulation of long non-coding RNA SNHG16 enhances progression and carcinogenesis in oral squamous cell carcinoma.
    Li S; Zhang S; Chen J
    Cancer Gene Ther; 2019 Nov; 26(11-12):400-410. PubMed ID: 30607006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of LncRNA SNHG16 Downregulates Cyclin D1 (CCND1) to Abrogate Malignant Phenotypes in Oral Squamous Cell Carcinoma (OSCC) Through Upregulating miR-17-5p.
    Wang Q; Han J; Xu P; Jian X; Huang X; Liu D
    Cancer Manag Res; 2021; 13():1831-1841. PubMed ID: 33654431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fucosterol exerts antiproliferative effects on human lung cancer cells by inducing apoptosis, cell cycle arrest and targeting of Raf/MEK/ERK signalling pathway.
    Mao Z; Shen X; Dong P; Liu G; Pan S; Sun X; Hu H; Pan L; Huang J
    Phytomedicine; 2019 Aug; 61():152809. PubMed ID: 31035050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA (lncRNA) Small Nucleolar RNA Host Gene 16 (SNHG16) Predicts Poor Prognosis and Sorafenib Resistance in Hepatocellular Carcinoma.
    Guo Z; Zhang J; Fan L; Liu J; Yu H; Li X; Sun G
    Med Sci Monit; 2019 Mar; 25():2079-2086. PubMed ID: 30893293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SNHG16 drives proliferation and invasion of papillary thyroid cancer through modulation of miR-497.
    Wen Q; Zhao L; Wang T; Lv N; Cheng X; Zhang G; Bai L
    Onco Targets Ther; 2019; 12():699-708. PubMed ID: 30705598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA SNHG16 promotes proliferation and inhibits apoptosis of diffuse large B-cell lymphoma cells by targeting miR-497-5p/PIM1 axis.
    Zhu Q; Li Y; Guo Y; Hu L; Xiao Z; Liu X; Wang J; Xu Q; Tong X
    J Cell Mol Med; 2019 Nov; 23(11):7395-7405. PubMed ID: 31483572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA SNHG16 contributes to osteosarcoma progression by acting as a ceRNA of miR-1285-3p.
    Xiao X; Jiang G; Zhang S; Hu S; Fan Y; Li G; Yu H; He S
    BMC Cancer; 2021 Apr; 21(1):355. PubMed ID: 33823834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA SNHG16 regulates human aortic smooth muscle cell proliferation and migration via sponging miR-205 and modulating Smad2.
    Lin Y; Tian G; Zhang H; Yuan W; Xie Y; Yang Y; Wang J; Liang Y
    J Cell Mol Med; 2019 Oct; 23(10):6919-6929. PubMed ID: 31441592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA SNHG16 Exerts Oncogenic Functions in Promoting Proliferation of Glioma Through Suppressing p21.
    Zhou XY; Liu H; Ding ZB; Xi HP; Wang GW
    Pathol Oncol Res; 2020 Apr; 26(2):1021-1028. PubMed ID: 30972632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA SNHG16 predicts poor prognosis in ESCC and promotes cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway.
    Han GH; Lu KJ; Wang P; Ye J; Ye YY; Huang JX
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3795-3803. PubMed ID: 29949155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.